BioSpace News Archive

Deals

Product Quest Manufacturing files for bankruptcy protection

Producer of OTC drugs and cosmetics ceases operations

September 7, 2018
·
1 min read
Bio NC

New Study Examines How Medical Device Industry can Boost Commercial Success in Emerging Markets

With an aging global population, increased health awareness, and growing income levels in many of the emerging markets, the need and opportunity for high-quality medical device solutions has never been greater in these regions.

September 7, 2018
·
2 min read
Deals

Kodiak Sciences Files Registration Statement for Proposed Initial Public Offering

Kodiak Sciences Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock.

September 7, 2018
·
1 min read
FDA

FDA clears development path for BTX 1204

Botanix held a Pre-IND Meeting with the FDA for the BTX 1204 atopic dermatitis product

September 7, 2018
·
1 min read
Business

VALBOTIS strengthens its Board of Directors and announces the appointment of Pascal SIRVENT

VALBIOTIS announces the appointment of Pascal SIRVENT to its Board of Directors.

September 7, 2018
·
3 min read
Business

Hugo Petit Appointed CFO of OxThera

OxThera AB today announced the appointment of Hugo Petit as its new Chief Financial Officer. Mr Petit previously served as the Chief Financial Officer of MedCap AB.

September 7, 2018
·
1 min read
Drug Development

Luye Pharma’s Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators

Luye Pharma announced that its independently developed drug, Goserelin Acetate Extended-release Microspheres for Injection (LY01005), has entered phase III clinical trials for prostate cancer in China.

September 7, 2018
·
4 min read
Genetown

MassBio’s® 2018 Industry Snapshot Shows 48% of All US-Based Biotech IPOs in 2017 Were from Massachusetts Companies

The Commonwealth continues to grab a greater share of venture capital dollars; investments reach all-time high

September 7, 2018
·
2 min read
Business

Regeneus Ltd (ASX:RGS) FY18 Results and Business Update

Regeneus Ltd is pleased to provide an overview of its results for the financial year ended 30 June 2018.

September 7, 2018
·
7 min read
Secarna Pharmaceuticals announces poster presentation on targeting RORgt with an innovative antisense oligonucleotides approach at the European Congress of Immunology

Secarna Pharmaceuticals announced today that results from preclinical studies targeting ROR(gamma)t with an innovative antisense oligonucleotide approach will be presented at the 5th European Congress of Immunology (ECI).

September 7, 2018
·
2 min read